QL1706-SOX vs SOX Alone as Neoadjuvant Therapy for Resectable Diffuse-Type Gastric Cancer
Clinical trial NCT07315035 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07315035
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2028-12-31
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.